Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Harvard Business School
Boehringer Ingelheim
Cantor Fitzgerald
Express Scripts
Daiichi Sankyo

Generated: December 16, 2017

DrugPatentWatch Database Preview

Glenmark Pharms Inc Company Profile

« Back to Dashboard

What is the competitive landscape for GLENMARK PHARMS INC, and what generic and branded alternatives to GLENMARK PHARMS INC drugs are available?

GLENMARK PHARMS INC has four approved drugs.

There is one tentative approval on GLENMARK PHARMS INC drugs.

Summary for Glenmark Pharms Inc

US Patents:0
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Pharms IncRANITIDINE HYDROCHLORIDEranitidine hydrochlorideTABLET;ORAL078542-002Nov 19, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Glenmark Pharms IncCALCIPOTRIENEcalcipotrieneOINTMENT;TOPICAL090633-001Mar 24, 2010RXNoYes► Subscribe► Subscribe► Subscribe
Glenmark Pharms IncLITHIUM CARBONATElithium carbonateTABLET, EXTENDED RELEASE;ORAL091544-001Dec 27, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Glenmark Pharms IncMUPIROCINmupirocin calciumCREAM;TOPICAL201587-001Jan 24, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Glenmark Pharms IncRANITIDINE HYDROCHLORIDEranitidine hydrochlorideTABLET;ORAL078542-001Nov 19, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Federal Trade Commission
Harvard Business School
Cantor Fitzgerald
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: